Korean: 노르비마토프로스트 ·
Prohibited MFDS prohibited ingredients
Conditions (official MFDS text, Korean):
Bimatoprost is the organic compound that conforms to the formula. In the United States, Bimatoprost may be used as an active pharmaceutical ingredient. For further information about the regulation of drug ingredients in the United States, see Introduction, Part A, Regulatory and Ingredient Use Information, and consult the U.S. Code of Federal Regulations.
Source: MFDS — cosmetic ingredient use restrictions · checked Oct 17, 2026
No specific rule on file.
No specific rule on file. The FDA regulates few cosmetic ingredients by name; no rule does not mean approval.
How Norbimatoprost is treated in 1 more market, from the overseas cosmetic regulation database compiled by Korea's MFDS. Always confirm with the regulator of that country before selling there.
| Market | Status | Conditions |
|---|---|---|
| CA Canada | Prohibited | — |
Source: MFDS cosmetic ingredient use restrictions — overseas regulations · checked Oct 17, 2026
NORBIMATOPROST 노르비마토프로스트
Information only, not medical advice. Rules change — always check the linked official source. If you are pregnant, have a skin condition or allergies, ask a dermatologist or pharmacist.
We found no specific rule for it in the EU's CosIng records. That is not an approval or a safety statement.
In Korea's MFDS records it is listed as “Prohibited” (MFDS — cosmetic ingredient use restrictions).
We found no specific rule for it in the FDA's records. That is not an approval or a safety statement.
Korea's MFDS standard Korean name is 노르비마토프로스트.